Wani binciken da aka yi kwanan nan ya binciko tasirin maganin oxygen na hyperbaric akan ayyukan zuciya na mutanen da ke fuskantar dogon COVID, wanda ke nufin batutuwan kiwon lafiya daban-daban waɗanda ke ci gaba ko sake faruwa bayan kamuwa da cutar ta SARS-CoV-2.
Waɗannan matsalolin na iya haɗawa da ƙwayar zuciya mara kyau da kuma ƙara haɗarin rashin aiki na zuciya. Masu binciken sun gano cewa shakar da matsi sosai, tsaftataccen iskar oxygen na iya taimakawa wajen inganta ciwon zuciya a cikin dogon marasa lafiya na COVID.
Farfesa Marina Leitman ce ta jagoranci binciken daga Makarantar Magunguna ta Sackler a Jami'ar Tel Aviv da Cibiyar Kiwon Lafiya ta Shamir a Isra'ila. Kodayake an gabatar da binciken a wani taro a watan Mayu 2023 da ƙungiyar jama'a ta Turai ta Turai ta Kungiyar Kwarewar Turai, ba ta yanke hukunci ba.
Dogon COVID da damuwar zuciya
Dogon COVID, wanda kuma ake kira da ciwon bayan-COVID, yana shafar kusan kashi 10-20% na mutanen da suka kamu da COVID-19. Yayin da yawancin mutane ke murmurewa gaba ɗaya daga ƙwayar cuta, ana iya gano dogon COVID lokacin da alamun suka ci gaba har na tsawon watanni uku bayan farkon alamun COVID-19.
Alamun dogon COVID sun ƙunshi batutuwan lafiya daban-daban, gami da gajeriyar numfashi, matsalolin fahimi (wanda ake nufi da hazo na kwakwalwa), baƙin ciki, da rikice-rikicen zuciya da yawa. Mutanen da ke da dogon COVID suna cikin haɗarin haɓaka cututtukan zuciya, gazawar zuciya, da sauran yanayi masu alaƙa.
Hatta mutanen da ba su da wata matsala ta zuciya da ta gabata ko kuma babbar haɗarin cututtukan zuciya sun sami waɗannan alamun, kamar yadda binciken da aka gudanar a cikin 2022 ya nuna.
Hanyoyin binciken
Dokta Leitman da abokan aikinta sun dauki majinyata 60 da ke fama da alamun COVID-19 na dogon lokaci, ko da bayan lokuta masu laushi zuwa matsakaici, suna ɗaukar akalla watanni uku. Kungiyar ta hada da wadanda ke kwance a asibiti da wadanda ba a asibiti ba.
Don gudanar da binciken su, masu bincike sun raba mahalarta zuwa kungiyoyi biyu: daya yana karbar hyperbaric oxygen far (HBOT) da kuma sauran samun hanyar simulated (sham). An yi aikin ba da gangan, tare da daidaitattun adadin batutuwa a cikin kowane rukuni. A cikin makonni takwas, kowane mutum yana yin zama biyar a kowane mako.
Ƙungiyar HBOT ta sami 100% oxygen a matsa lamba na yanayi 2 na minti 90, tare da gajeren hutu kowane minti 20. A gefe guda kuma, ƙungiyar sham ta sami 21% oxygen a matsa lamba na yanayi 1 na tsawon lokaci guda amma ba tare da wani hutu ba.
Bugu da ƙari, duk mahalarta sunyi aikin echocardiography, gwaji don tantance aikin zuciya, kafin zaman HBOT na farko da 1 zuwa 3 makonni bayan zaman karshe.
A farkon binciken, 29 daga cikin mahalarta 60 suna da matsakaicin ƙimar tsayin daka na duniya (GLS) na -17.8%. Daga cikin su, an sanya 16 zuwa rukunin HBOT, yayin da sauran 13 ke cikin rukunin sham.
Sakamakon binciken
Bayan shan jiyya, ƙungiyar shiga tsakani ta sami babban haɓaka a matsakaicin GLS, wanda ya kai -20.2%. Hakazalika, ƙungiyar sham kuma ta sami karuwa a matsakaicin GLS, wanda ya kai -19.1%. Duk da haka, kawai ma'auni na farko ya nuna bambanci mai mahimmanci idan aka kwatanta da ma'auni na farko a farkon binciken.
Dokta Leitman ya lura cewa kusan rabin dogon marasa lafiya na COVID sun nakasa aikin zuciya a farkon binciken, kamar yadda GLS ya nuna. Duk da haka, duk mahalarta binciken sun baje kolin ɓangarorin fitarwa na yau da kullun, wanda shine ma'auni na yau da kullun da ake amfani da shi don tantance ƙarfin zuciya da natsuwa yayin bugun jini.
Dr. Leitman ya kammala da cewa juzu'in fitar da shi kadai ba shi da hankali isa ya gano dogon marasa lafiya na COVID wadanda watakila sun rage aikin zuciya.
Yin amfani da iskar oxygen na iya haifar da fa'idodi masu yawa.
A cewar Dr. Morgan, binciken binciken ya nuna kyakkyawan yanayin tare da hyperbaric oxygen far.
Duk da haka, ta ba da shawarar yin taka tsantsan, tare da bayyana cewa hyperbaric oxygen far ba magani ne da aka yarda da shi a duniya ba kuma yana buƙatar ƙarin bincike. Bugu da ƙari, akwai damuwa game da yiwuwar karuwa a cikin arrhythmias bisa wasu bincike.
Dokta Leitman da abokan aikinta sun kammala cewa hyperbaric oxygen far na iya zama da fa'ida ga marasa lafiya da dogon COVID. Ta ba da shawarar cewa ƙarin bincike ya zama dole don gano waɗanda marasa lafiya za su fi amfana, amma yana iya zama fa'ida ga duk masu dogon lokaci na COVID don yin kima na nau'in tsayin daka na duniya kuma suyi la'akari da maganin oxygen na hyperbaric idan aikin zuciyar su ya lalace.
Dokta Leitman ya kuma bayyana fatan cewa ƙarin karatu zai iya samar da sakamako na dogon lokaci da kuma taimakawa masu sana'a na kiwon lafiya wajen ƙayyade mafi kyawun adadin hyperbaric oxygen far zaman.
Lokacin aikawa: Agusta-05-2023